Source comparison
Tesamorelin + Other Peptides: Safe Stacking Comparison
Tesamorelin + Ipamorelin GHRH receptor + ghrelin receptor dual activation High. Minimal receptor competition Tesamorelin morning / Ipamorelin 3–4 hours later Best overall stack for sustained GH elevation with low desensitisation risk Tesamorelin + GHRP-2 Moder
This comparison does not assign a generated winner or score.
- Tesamorelin + Ipamorelin
- GHRH receptor + ghrelin receptor dual activation
- High. Minimal receptor competition
- Tesamorelin morning / Ipamorelin 3–4 hours later
- Best overall stack for sustained GH elevation with low desensitisation risk
- Tesamorelin + GHRP-2
- Moderate-high. GHRP-2 elevates cortisol more than ipamorelin
- Tesamorelin morning / GHRP-2 pre-workout
- Effective for research focused on peak GH amplitude. Cortisol rise may interfere with sleep quality
- Tesamorelin + Hexarelin
- GHRH receptor + high-affinity ghrelin receptor activation
- High short-term. Desensitises faster than ipamorelin
- Tesamorelin morning / Hexarelin evening (4–6 week cycles only)
- Maximal lipolysis in short protocols. Not sustainable beyond 6 weeks without receptor recovery
- Tesamorelin + MK-677
- GHRH receptor pulsatile + ghrelin receptor continuous stimulation
- Moderate. MK-677's continuous action accelerates desensitisation
- Tesamorelin morning / MK-677 before bed (5 days on / 2 off)
- Elevates baseline GH effectively but requires cycling to prevent ghrelin receptor downregulation
- Tesamorelin + CJC-1295 (no DAC)
- GHRH receptor competition. Same pathway
- Low. Redundant without synergy
- Not recommended
- No benefit over tesamorelin alone. Compounds compete for identical receptors
- Tesamorelin + CJC-1295 (with DAC)
- GHRH receptor continuous saturation
- Negative. Accelerates receptor downregulation
- Continuous GHRH stimulation prevents pulsatile signalling and reduces GH response by week 3–4